| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Division of Endocrinology and Metabolism (W.F.S., M.A.L.), Department of Medicine and Division of Developmental Genetics (K.J.R., A.M.L., J.D.G.), Department of Gynecology and Obstetrics, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
Address all correspondence and requests for reprints to: William F. Schwindinger, Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, Ross 863, 720 Rutland Avenue, Baltimore, Maryland 21205. E-mail: wschwind{at}welchlink.welch.jhu.edu
Mutations in the gene encoding the stimulatory G protein of adenylyl
cyclase (G
s) are present in subjects with Albright
hereditary osteodystrophy, a syndrome of characteristic developmental
defects and, in some patients, resistance to multiple hormones that
stimulate cAMP accumulation (pseudohypoparathyroidism type Ia). As the
first step in generating a model of Albright hereditary osteodystrophy,
the gene encoding G
s (Gnas) was disrupted
in mouse embryonic stem (ES) cells by homologous recombination.
Northern blot analysis and immunoblot analysis demonstrated that
steady-state levels of G
s messenger RNA and
G
s protein in targeted ES cells were approximately 50%
of levels in untargeted ES cells. In response to 10 µM
forskolin and to various concentrations of isoproterenol (0.13.0
µM), cAMP accumulation was reduced in the
G
s knockout ES cell lines, relative to wild-type ES
cells and to five of six ES cell lines with randomly integrated
targeting vector. These results support the role of G
s
haploinsufficiency in reducing the ability of hormones to generate cAMP
in subjects with pseudohypoparathyroidism type Ia. The targeted
disruption of Gnas in mouse ES cells establishes an
in vitro system for further studies of the role of
G
s and cAMP coupled signal transduction in
differentiation and development.
This article has been cited by other articles:
![]() |
S. C. Hsu, J. D. Groman, C. A. Merlo, K. Naughton, P. L. Zeitlin, E. L. Germain-Lee, M. P. Boyle, and G. R. Cutting Patients with Mutations in Gs{alpha} Have Reduced Activation of a Downstream Target in Epithelial Tissues due to Haploinsufficiency J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3941 - 3948. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Germain-Lee, W. Schwindinger, J. L. Crane, R. Zewdu, L. S. Zweifel, G. Wand, D. L. Huso, M. Saji, M. D. Ringel, and M. A. Levine A Mouse Model of Albright Hereditary Osteodystrophy Generated by Targeted Disruption of Exon 1 of the Gnas Gene Endocrinology, November 1, 2005; 146(11): 4697 - 4709. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Wand, M. Levine, L. Zweifel, W. Schwindinger, and T. Abel The cAMP-Protein Kinase A Signal Transduction Pathway Modulates Ethanol Consumption and Sedative Effects of Ethanol J. Neurosci., July 15, 2001; 21(14): 5297 - 5303. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Fischer, F. Egert, E. Werder, and W. Born An Inherited Mutation Associated with Functional Deficiency of the {alpha}-Subunit of the Guanine Nucleotide-Binding Protein Gs in Pseudo- and Pseudopseudohypoparathyroidism J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 935 - 938. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |